We are excited to see our portfolio company StratifAI selected to join the Memorial Sloan Kettering (MSK) iHub Challenge Cohort. It is a major milestone in advancing their fully digital, multimodal AI platform, Polaris™. Designed to overcome the limitations of traditional biomarker discovery, Polaris™ transforms routine clinical data into novel, scalable biomarkers for precision oncology, eliminating the need for costly and specialized inputs. Through this prestigious collaboration, StratifAI gains access to MSK’s world-class clinical datasets, enabling crucial validation on real-world evidence as the platform targets regulatory approval and guideline inclusion in the EU and US.
